Bromazine

Bromazine
Clinical data
Trade names	Ambodryl, Ambrodil, Deserol
Other names	Bromodiphenhydramine; Bromdiphenhydramine
MedlinePlus	a682065
Routes of; administration	Oral
ATC code	R06AA01 (WHO) ;
Pharmacokinetic data
Bioavailability	High
Protein binding	96%
Metabolism	Mostly hepatic (CYP-mediated), also renal
Elimination half-life	1 to 4 hours
Identifiers
	IUPAC name 2-[(4-Bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine;
CAS Number	1808-12-4 1808-12-4;
PubChem CID	2444;
IUPHAR/BPS	7132;
DrugBank	DB01237 ;
ChemSpider	2350 ;
UNII	202J683U97;
ChEBI	CHEBI:59177 ;
ChEMBL	ChEMBL1201245 ;
CompTox Dashboard (EPA)	DTXSID6022688 ;
ECHA InfoCard	100.003.854
Chemical and physical data
Formula	C17H20BrNO
Molar mass	334.257 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Brc1ccc(cc1)C(OCCN(C)C)c2ccccc2;
	InChI InChI=1S/C17H20BrNO/c1-19(2)12-13-20-17(14-6-4-3-5-7-14)15-8-10-16(18)11-9-15/h3-11,17H,12-13H2,1-2H3 ; Key:NUNIWXHYABYXKF-UHFFFAOYSA-N ;
	(what is this?) (verify)

Bromazine, sold under the brand names Ambodryl, Ambrodil, and Deserol among others, also known as bromodiphenhydramine, is an antihistamine and anticholinergic medication of the ethanolamine class. It is an analogue of diphenhydramine with a bromine substitution on one of the phenyl rings.